S&P 500   3,750.77
DOW   30,303.17
QQQ   319.43
S&P 500   3,750.77
DOW   30,303.17
QQQ   319.43
S&P 500   3,750.77
DOW   30,303.17
QQQ   319.43
S&P 500   3,750.77
DOW   30,303.17
QQQ   319.43
Log in
CVE:HTL

Hamilton Thorne Ltd. (HTL.V) Stock Forecast, Price & News

C$1.37
-0.04 (-2.84 %)
(As of 01/27/2021 03:46 PM ET)
Add
Compare
Today's Range
C$1.37
Now: C$1.37
C$1.41
50-Day Range
C$0.01
MA: C$1.35
C$1.42
52-Week Range
C$0.90
Now: C$1.37
C$1.50
Volume6,892 shs
Average Volume224,171 shs
Market CapitalizationC$189.58 million
P/E Ratio195.71
Dividend YieldN/A
BetaN/A
Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers laser products used in a range of scientific applications and in vitro fertilization (IVF) procedures; and image analysis systems used in the studies of reproductive cells in the human fertility, animal sciences, and reproductive toxicology fields. The company also provides micromanipulation systems that assists the embryologist in performing critical procedures in the IVF lab under the TrakJector brand; a line of air filtration products to enhance air quality in the laboratory under the ZANDAIR brand; incubators, control rate freezers, and lab monitoring systems for the ART and cell biology markets under the Planer brand; and reproductive medicine, including clinical and laboratory equipment, and disposables, as well as installations of ART clinics under the Gynemed brand. In addition, it offers GM501 family of products, which provides the IVF lab with a range of cell culture media solution, including oocyte handling, sperm processing, embryo culture, and cryopreservation; quality control assays used in IVF labs for testing equipment and materials' toxicity under the Embryotech brand; and glass micropipettes. Further, the company provides equipment service contract and maintenance programs; quality control testing services to manufacturers of medical devices, culture media, and consumables used in IVF labs; and laboratory design and installation services. Additionally, it distributes a range of specialized equipment, software, accessories, and consumables. The company sells its products through direct sales force and distributors to pharmaceutical and biotechnology companies, fertility clinics, university research centers, and other commercial and academic research establishments worldwide. Hamilton Thorne Ltd. is headquartered in Beverly, Massachusetts.

MarketRank

Overall MarketRank

1.61 out of 5 stars

Analyst Opinion: 3.5Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-978-9212050
EmployeesN/A
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$38.36 million
Cash FlowC$0.14 per share
Book ValueC$0.35 per share

Profitability

Miscellaneous

Market CapC$189.58 million
Next Earnings Date4/28/2021 (Estimated)
OptionableNot Optionable
C$1.37
-0.04 (-2.84 %)
(As of 01/27/2021 03:46 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive HTL News and Ratings via Email

Sign-up to receive the latest news and ratings for HTL and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Hamilton Thorne Ltd. (HTL.V) (CVE:HTL) Frequently Asked Questions

How has Hamilton Thorne Ltd. (HTL.V)'s stock price been impacted by COVID-19?

Hamilton Thorne Ltd. (HTL.V)'s stock was trading at C$1.21 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, HTL stock has increased by 13.2% and is now trading at C$1.37.
View which stocks have been most impacted by COVID-19
.

Is Hamilton Thorne Ltd. (HTL.V) a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Hamilton Thorne Ltd. (HTL.V) in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Hamilton Thorne Ltd. (HTL.V) stock.
View analyst ratings for Hamilton Thorne Ltd. (HTL.V)
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Hamilton Thorne Ltd. (HTL.V)?

Wall Street analysts have given Hamilton Thorne Ltd. (HTL.V) a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Hamilton Thorne Ltd. (HTL.V) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Hamilton Thorne Ltd. (HTL.V)'s next earnings date?

Hamilton Thorne Ltd. (HTL.V) is scheduled to release its next quarterly earnings announcement on Wednesday, April 28th 2021.
View our earnings forecast for Hamilton Thorne Ltd. (HTL.V)
.

What price target have analysts set for HTL?

3 equities research analysts have issued 1 year target prices for Hamilton Thorne Ltd. (HTL.V)'s stock. Their forecasts range from C$1.70 to C$1.85. On average, they anticipate Hamilton Thorne Ltd. (HTL.V)'s share price to reach C$1.79 in the next twelve months. This suggests a possible upside of 30.5% from the stock's current price.
View analysts' price targets for Hamilton Thorne Ltd. (HTL.V)
or view Wall Street analyst' top-rated stocks.

Who are some of Hamilton Thorne Ltd. (HTL.V)'s key competitors?

What other stocks do shareholders of Hamilton Thorne Ltd. (HTL.V) own?

Who are Hamilton Thorne Ltd. (HTL.V)'s key executives?

Hamilton Thorne Ltd. (HTL.V)'s management team includes the following people:
  • Ms. Meg Spencer, Co-Founder & Chairman
  • Mr. David B. Wolf, Pres, CEO & Director
  • Mr. Diarmaid H. Douglas-Hamilton, Co-Founder, Sr. VP of R&D, CTO, Corp. Sec. and Director
  • Mr. Michael W. Bruns, VP of Fin. & CFO (Age 64, Pay $233.88k)
  • Dr. Fabian Sell, Chief Exec. Officer of Gynemed
  • Mr. Keith F. Edwards, Sr. VP & GM
  • Mr. Eric V. Dorman, Pres of Embryotech Laboratories Inc

What is Hamilton Thorne Ltd. (HTL.V)'s stock symbol?

Hamilton Thorne Ltd. (HTL.V) trades on the Canadian Venture Exchange (CVE) under the ticker symbol "HTL."

How do I buy shares of Hamilton Thorne Ltd. (HTL.V)?

Shares of HTL and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What is Hamilton Thorne Ltd. (HTL.V)'s stock price today?

One share of HTL stock can currently be purchased for approximately C$1.37.

How big of a company is Hamilton Thorne Ltd. (HTL.V)?

Hamilton Thorne Ltd. (HTL.V) has a market capitalization of C$189.58 million and generates C$38.36 million in revenue each year.

What is Hamilton Thorne Ltd. (HTL.V)'s official website?

The official website for Hamilton Thorne Ltd. (HTL.V) is www.hamiltonthorne.com.

How can I contact Hamilton Thorne Ltd. (HTL.V)?

Hamilton Thorne Ltd. (HTL.V)'s mailing address is 100 Cummings Ctr Ste 465e, BEVERLY, MA 01915-6143, United States. The company can be reached via phone at +1-978-9212050.

This page was last updated on 1/28/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.